Cargando…

Improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs

A commentary in Nature entitled "Towards responsible use of cognitive-enhancing drugs by the healthy" (Greely et al 2008 Nature 456: 702–705) offers an opportunity to move toward a humane societal appreciation of mind-altering drugs. Using cognitive enhancing drugs as an exemplar, this art...

Descripción completa

Detalles Bibliográficos
Autor principal: Thaler, David S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702330/
https://www.ncbi.nlm.nih.gov/pubmed/19531231
http://dx.doi.org/10.1186/1477-7517-6-10
_version_ 1782168760009883648
author Thaler, David S
author_facet Thaler, David S
author_sort Thaler, David S
collection PubMed
description A commentary in Nature entitled "Towards responsible use of cognitive-enhancing drugs by the healthy" (Greely et al 2008 Nature 456: 702–705) offers an opportunity to move toward a humane societal appreciation of mind-altering drugs. Using cognitive enhancing drugs as an exemplar, this article presents a series of hypotheses concerning how an individual might learn optimal use. The essence of the proposal is that individuals can cultivate sensitivity to the effects of ever-smaller amounts of psychoactive drugs thereby making harm less likely and benign effects more probable. Four interrelated hypotheses are presented and briefly discussed. 1. Humans can learn to discriminate ever-smaller doses of at least some mind-altering drugs; a learning program can be designed or discovered that will have this outcome. 2. The skill to discriminate drugs and dose can be generalized, i.e. if learned with one drug a second one is easier and so on. 3. Cultivating this skill/knack would be beneficial in leading to choices informed by a more accurate sense of mind-body interactions. 4. From a philosophical point of view learning the effects of ever-smaller doses of psychoactive agents offers a novel path into and to transcend the objective/subjective barrier and the mind/body problem. Whatever the fate of these specific hypotheses, discussion of cognitive enhancing drugs for healthy individuals has the potential to inspire innovative educational and public policy initiatives toward all types of mind-altering drugs and the people who use them.
format Text
id pubmed-2702330
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27023302009-06-27 Improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs Thaler, David S Harm Reduct J Commentary A commentary in Nature entitled "Towards responsible use of cognitive-enhancing drugs by the healthy" (Greely et al 2008 Nature 456: 702–705) offers an opportunity to move toward a humane societal appreciation of mind-altering drugs. Using cognitive enhancing drugs as an exemplar, this article presents a series of hypotheses concerning how an individual might learn optimal use. The essence of the proposal is that individuals can cultivate sensitivity to the effects of ever-smaller amounts of psychoactive drugs thereby making harm less likely and benign effects more probable. Four interrelated hypotheses are presented and briefly discussed. 1. Humans can learn to discriminate ever-smaller doses of at least some mind-altering drugs; a learning program can be designed or discovered that will have this outcome. 2. The skill to discriminate drugs and dose can be generalized, i.e. if learned with one drug a second one is easier and so on. 3. Cultivating this skill/knack would be beneficial in leading to choices informed by a more accurate sense of mind-body interactions. 4. From a philosophical point of view learning the effects of ever-smaller doses of psychoactive agents offers a novel path into and to transcend the objective/subjective barrier and the mind/body problem. Whatever the fate of these specific hypotheses, discussion of cognitive enhancing drugs for healthy individuals has the potential to inspire innovative educational and public policy initiatives toward all types of mind-altering drugs and the people who use them. BioMed Central 2009-06-16 /pmc/articles/PMC2702330/ /pubmed/19531231 http://dx.doi.org/10.1186/1477-7517-6-10 Text en Copyright © 2009 Thaler; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Thaler, David S
Improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs
title Improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs
title_full Improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs
title_fullStr Improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs
title_full_unstemmed Improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs
title_short Improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs
title_sort improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702330/
https://www.ncbi.nlm.nih.gov/pubmed/19531231
http://dx.doi.org/10.1186/1477-7517-6-10
work_keys_str_mv AT thalerdavids improvingintrospectiontoinformfreewillregardingthechoicebyhealthyindividualstouseornotusecognitiveenhancingdrugs